| Regulatory Story | ||||||||||||
| Go to market news section |
|
|||||||||||
|
||||||||||||
RNS Number : 4886Z
Reed Elsevier PLC
07 March 2013
ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
("REED ELSEVIER")
7 March 2013
Director Shareholding
Reed Elsevier received notification yesterday, that on 6 March 2013, Mr Duncan Palmer, a director of Reed Elsevier, purchased 22 Reed Elsevier PLC ADRs, at a price of $44.23 per ADR and 63 Reed Elsevier NV ADRs at a price of $31.51 per ADR. Each Reed Elsevier PLC ADR represents four Reed Elsevier ordinary shares and each Reed Elsevier NV ADR represents two Reed Elsevier NV ordinary shares.
As a result of this transaction, Mr Palmer's current interest in Reed Elsevier's ordinary share capital is:
· 88 Reed Elsevier PLC ordinary shares; and
· 126 Reed Elsevier NV ordinary shares.
This information is provided by RNS
The company news service from the London Stock Exchange
 |
 |
| London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
| © London Stock Exchange plc. All rights reserved |